Abstract
The authors discuss results from an early trial of a vaccine based on Plasmodium MSP-3 protein reported by Pierre Druilhe and colleagues.
MeSH terms
-
Adjuvants, Immunologic
-
Animals
-
Antibody Formation*
-
Clinical Trials as Topic
-
Humans
-
Malaria Vaccines / immunology*
-
Malaria, Falciparum / prevention & control*
-
Plasmodium falciparum / immunology
-
Plasmodium falciparum / pathogenicity
Substances
-
Adjuvants, Immunologic
-
Malaria Vaccines